118 related articles for article (PubMed ID: 1703332)
1. Monoclonal antibodies specific for a conformationally altered state of fibrinogen.
Zamarron C; Ginsberg MH; Plow EF
Thromb Haemost; 1990 Aug; 64(1):41-6. PubMed ID: 1703332
[TBL] [Abstract][Full Text] [Related]
2. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
3. Two monoclonal antibodies to D-dimer-specific inhibitors of fibrin polymerization.
Lugovskoy EV; Gritsenko PG; Kolesnikova IN; Zolotarova EN; Chernishov VI; Nieuwenhuizen W; Komisarenko SV
Thromb Res; 2004; 113(3-4):251-9. PubMed ID: 15140590
[TBL] [Abstract][Full Text] [Related]
4. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
[TBL] [Abstract][Full Text] [Related]
5. The study of fibrin polymerization with monoclonal antibodies.
Lugovskoi EV; Makogonenko EM; Chudnovets VS; Derzskaya SG; Gogolinskaya GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Lyashko ED; Komissarenko SV
Biomed Sci; 1991; 2(3):249-56. PubMed ID: 1751757
[TBL] [Abstract][Full Text] [Related]
6. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a monoclonal antibody, D73H, that maps to a highly conserved region on fibrinogen Bbeta chain.
Rybarczyk BJ; Pereira M; Simpson-Haidaris PJ
Thromb Haemost; 2000 Jul; 84(1):43-8. PubMed ID: 10928468
[TBL] [Abstract][Full Text] [Related]
8. Modification of fibrin network ultrastructure by Fab fragments specific for different domain of fibrinogen.
Cierniewski CS; Janiak A; Wyroba E
Acta Biochim Pol; 1986; 33(3):195-202. PubMed ID: 2433859
[TBL] [Abstract][Full Text] [Related]
9. The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.
Lu PD; Galanakis DK; Ghebrehiwet B; Peerschke EI
Clin Immunol; 1999 Mar; 90(3):360-7. PubMed ID: 10075865
[TBL] [Abstract][Full Text] [Related]
10. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
11. A novel mechanism for exposure of fibrinogen binding sites on GPIIb-IIIa by a monoclonal antibody.
Hato T; Watanabe A; Nakatani S; Minamoto Y; Fujita S
Thromb Haemost; 1995 Jan; 73(1):138-43. PubMed ID: 7537917
[TBL] [Abstract][Full Text] [Related]
12. Screening for fibrin specific monoclonal antibodies: the development of a new procedure.
Tymkewycz PM; Creighton-Kempsford LJ; Hockley D; Gaffney PJ
Thromb Haemost; 1992 Jul; 68(1):48-53. PubMed ID: 1514172
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.
Mao SJ; Rechtin AE; Krstenansky JL; Jackson RL
Thromb Haemost; 1990 Jun; 63(3):445-8. PubMed ID: 2402748
[TBL] [Abstract][Full Text] [Related]
14. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Dempfle CE
Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
[TBL] [Abstract][Full Text] [Related]
15. Recognition of two Dermatophagoides pteronyssinus-specific epitopes on antigen P1 by using monoclonal antibodies: binding to each epitope can be inhibited by serum from dust mite-allergic patients.
Chapman MD; Sutherland WM; Platts-Mills TA
J Immunol; 1984 Nov; 133(5):2488-95. PubMed ID: 6207232
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the factors contributing to fibrin-dependent plasminogen activation.
Mosesson MW; Siebenlist KR; Voskuilen M; Nieuwenhuizen W
Thromb Haemost; 1998 Apr; 79(4):796-801. PubMed ID: 9569195
[TBL] [Abstract][Full Text] [Related]
17. Validation, calibration, and specificity of quantitative D-dimer assays.
Dempfle CE
Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
[TBL] [Abstract][Full Text] [Related]
18. Adsorption of fibrinogen and fragment D of fibrinogen onto the insolubilized alpha-chain of fibrin.
Matthias FR
Thromb Haemost; 1979 Jun; 41(4):687-90. PubMed ID: 483242
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody that recognizes a neo-antigen exposed in the E domain of fibrin monomer complexed with fibrinogen or its derivatives: its application to the measurement of soluble fibrin in plasma.
Soe G; Kohno I; Inuzuka K; Itoh Y; Matsuda M
Blood; 1996 Sep; 88(6):2109-17. PubMed ID: 8822930
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
Raut S; Gaffney PJ
Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
